Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Aventis Pharmaceuticals
Information provided by:
Munich Municipal Hospital
ClinicalTrials.gov Identifier:
NCT01035528
First received: December 17, 2009
Last updated: NA
Last verified: August 2004
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2010
  Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)